This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
ADSTILADRIN
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
ESCAPE
FORT
NRG-GU 0101
Masofaniten (EPI-7386)
METANOVA
RTIRE
SHORTER
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
EAU 2024
SESAUA 2024
Southern CA GU Cancer Research Forum 2024
AUA Urology Advocacy Summit 2024
ASCO GU 2024
2024 UCSF-UCLA PSMA Conference
All Conferences
View All
PCF
UroToday Home
Conference Highlights
EAU 2018
EAU 2018
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testis and Penile Cancer
Endourology
Press
EAU 2018 Kidney Cancer
Viewing 15-34 of 38 articles
EAU 2018: The Learning Curve for Robot-Assisted Partial Nephrectomy: Impact of Surgical Experience on Perioperative Outcomes
EAU 2018: New Techniques in Renal Puncture During Percutaneous Nephrolithotomy Did They Make It Safer And Easier?
EAU 2018: Anticipating The Effect Of Selective Referral On Overall Survival Following Cytoreductive Nephrectomy
EAU 2018: Impact Of Hospital Nephrectomy Volume On Intermediate To Long-term Survival In Renal Cell Carcinoma
EAU 2018: Risk-based Surveillance After Surgical Treatment of Renal Cell Carcinoma
EAU 2018: Minimally Invasive Surgery for Kidney Cancer With Venous Thrombus: Oncological and Functional Outcomes From a Multicentre Series
EAU 2018: The role of histologic subtypes in follow-up scheme of postsurgical kidney cancer patients
EAU 2018: Trends and Morbidity for Minimally Invasive vs Open Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma
EAU 2018: Dividing Pathologically Upstaged T3a Renal Cell Carcinoma is Associated with Improved Alignment of Outcomes: A call for TMN Revision
EAU 2018: U-SMART: (UCSD small mass ALT RENAL score tumor diameter) A novel scoring system of preoperative predictors to stratify oncologic risk of small renal masses
EAU 2018: MR Spectroscopy Distinguishes Histologically-diagnosed Kidney Tissue
EAU 2018: Cost Benefit Analysis Favors Sonographic Screening For Renal Tumors
EAU 2018: Survival Analyses of Patients with Metastatic Renal Cancer Treated with Targeted Therapy With or Without Cytoreductive Nephrectomy
EAU 2018: Immediate and Late Complications of Robotic Partial Nephrectomy
EAU 2018: Renal Cancer: Partial Nephrectomy, Immediate and Late Complications – Open Technique
EAU 2018: Renal Cancer: Partial Nephrectomy, Immediate and Late Complications - Laparoscopic
EAU 2018: Does Renal Biopsy Make Sense in View of Tumor Heterogeneity?
EAU 2018: Endoscopic Combined Intrarenal Surgery with Disposable Ureteroscope: Bilateral Synchronous Treatment
EAU 2018: Systematic Review and Meta-Analysis of Adjuvant Therapy after Nephrectomy for High-Risk, Non-Metastatic Renal Cell Carcinoma
EAU 2018: Natural History of Collecting Duct Carcinoma: A Unique Multi-Institutional Study with a Centrally-Reviewed Pathology
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free